Cargando…

The Role of Thyrotrophin Receptor Antibody Assays in Graves' Disease

Thyrotrophin receptor antibodies (TRAb) exist as stimulating or blocking antibodies in the serum (neutral TRAb have been identified recently). The clinical features of GD occur when stimulating TRAb predominate. But the relationship of TRAb to clinical phenotype and outcome is not clear when current...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamath, C., Adlan, M. A., Premawardhana, L. D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345237/ https://www.ncbi.nlm.nih.gov/pubmed/22577596 http://dx.doi.org/10.1155/2012/525936

Ejemplares similares

Managing thymic enlargement in Graves’ disease
por: Kamath, C, et al.
Publicado: (2019)

Clinical Significance of Thyrotrophin Binding Inhibitor Immunoglobulins in Patients with Graves’ Disease and Various Types of Thyroiditis
por: Lee, Chong Suk, et al.
Publicado: (1987)

Thyrotrophin and thyroxine support immune homeostasis in humans
por: Jaeger, Martin, et al.
Publicado: (2021)

Thyroid Peroxidase Antibody and Screening for Postpartum Thyroid Dysfunction
por: Adlan, Mohamed A., et al.
Publicado: (2011)

Presentation and Outcome of Severe Graves’ Disease
por: Babu, Priya Mohan, et al.
Publicado: (2021)

Thyrotrophin receptors, tumour radioiodine concentration and thyroglobulin secretion in differentiated thyroid cancers.
por: Edmonds, C. J., et al.
Publicado: (1985)

Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy
por: Deng, Zhihong, et al.
Publicado: (2021)

Advances in Graves' Disease
por: Galofré, Juan C., et al.
Publicado: (2012)

Combined prognostic value of preoperative serum thyrotrophin and thyroid hormone concentration in papillary thyroid cancer
por: Liu, Yushu, et al.
Publicado: (2022)

Newer Dopaminergic Agents Cause Minimal Endocrine Effects in Idiopathic Parkinson’s Disease
por: Daniel, Jacob S, et al.
Publicado: (2014)

Thyrotropin receptor antibodies and Graves’ orbitopathy
por: Diana, T., et al.
Publicado: (2020)

Significant cardiac disease complicating Graves’ disease in previously healthy young adults
por: Witczak, J K, et al.
Publicado: (2019)

Correlation between TSH Receptor Antibody Assays and Clinical Manifestations of Graves' Orbitopathy
por: Jang, Sun Young, et al.
Publicado: (2013)

Comparative performance of ELISA and dot blot assay for TSH‐receptor antibody detection in Graves’ disease
por: Zulkarnain, Zulkarnain, et al.
Publicado: (2022)

Comparison of Five TSH-Receptor Antibody Assays in Graves’ disease: results from an observational pilot study
por: Struja, Tristan, et al.
Publicado: (2019)

Prospective Trial of Functional Thyrotropin Receptor Antibodies in Graves Disease
por: Kahaly, George J, et al.
Publicado: (2019)

Rab1b overexpression modifies Golgi size and gene expression in HeLa cells and modulates the thyrotrophin response in thyroid cells in culture
por: Romero, Nahuel, et al.
Publicado: (2013)

Diurnal and photoperiodic changes in thyrotrophin‐stimulating hormone β expression and associated regulation of deiodinase enzymes (DIO2, DIO3) in the female juvenile chicken hypothalamus
por: Dunn, I. C., et al.
Publicado: (2017)

Correction to: Thyrotropin receptor antibodies and Graves’ orbitopathy
por: Diana, T., et al.
Publicado: (2021)

Clinical diagnosis of Graves’ or non-Graves’ hyperthyroidism compared to TSH receptor antibody test
por: Bell, Lauren, et al.
Publicado: (2018)

TSH-receptor antibodies may prevent bone loss in pre- and postmenopausal women with Graves' disease and Graves' orbitopathy
por: Siderova, Mira, et al.
Publicado: (2018)

Cut-Off Value of Thyrotropin-Receptor Antibodies in Grave’s Disease in Basrah
por: Radhi, Maher A, et al.
Publicado: (2023)

A Retroperitoneal Leiomyosarcoma Presenting as an Adrenal Incidentaloma in a Subject on Warfarin
por: Khan, Ishrat N., et al.
Publicado: (2015)

The Role of the Microbiota in Graves’ Disease and Graves’ Orbitopathy
por: Hou, Jueyu, et al.
Publicado: (2021)

Clinical Significance of Classification of Graves’ Disease According to the Characteristics of TSH Receptor Antibodies
por: Kim, Won Bae, et al.
Publicado: (2001)

The Role of Oxidative Stress on the Pathogenesis of Graves' Disease
por: Žarković, Miloš
Publicado: (2012)

Microchimerism in Graves' Disease
por: Galofré, Juan C.
Publicado: (2012)

Myositis, rhabdomyolysis and severe hypercalcaemia in a body builder
por: Ravindran, Ravikumar, et al.
Publicado: (2020)

Changes in the Properties of the Thyrotropin Receptor Antibody in Patients with Graves’ Disease after Radioiodine Treatment
por: Cho, Bo Youn, et al.
Publicado: (1990)

Evaluation of the diagnostic performance of thyroid‐stimulating immunoglobulin and thyrotropin receptor antibodies for Graves' disease
por: Xu, Shiji, et al.
Publicado: (2023)

Stimulatory Thyrotropin Receptor Antibodies Are a Biomarker for Graves’ Orbitopathy
por: George, Augustine, et al.
Publicado: (2021)

The Evolving Role of Selenium in the Treatment of Graves' Disease and Ophthalmopathy
por: Duntas, Leonidas H.
Publicado: (2012)

Anti-nuclear autoantibodies in Graves’ disease and Graves’ orbitopathy
por: Lanzolla, G., et al.
Publicado: (2022)

Graves’ disease: moving forwards
por: Lane, Laura C, et al.
Publicado: (2023)

Thyrotropin Binding Inhibiting Antibody (TBIAb) in Graves’ Disease
por: Cho, Won Yong, et al.
Publicado: (1988)

Antibodies against thyroid-stimulating hormone receptor cause maternal-neonatal transmission of Graves' Disease
por: Yu, Yue, et al.
Publicado: (2021)

Pre-test Cortisol Levels in Predicting Short Synacthen Test Outcome: A Retrospective Analysis
por: Ravindran, Ravikumar, et al.
Publicado: (2022)

Graves' Disease: Can It Be Cured?
por: Wiersinga, Wilmar M.
Publicado: (2019)

OR18-03 Functional TSH Receptor Antibodies Are a Biomarker for Graves’ Disease - a Prospective Trial
por: Kahaly, George Jean, et al.
Publicado: (2020)

Graves of Graves' Disease, 1796—1853
por: Taylor, Selwyn
Publicado: (1986)

Cannot write session to /tmp/vufind_sessions/sess_fq8o8p5ar67rglbbal4oggdiss